Clinical event rates were still no different with longer follow-up, but one investigator thinks an advantage will emerge in ...

Valvular heart disease – where excessively tight or leaky connections between heart chambers gradually wear out the heart – affects up to 10% of older adults and causes more than 120,000 deaths a year ...

ALL WOMEN reported alongside 3-year data from SMART ...

PORTLAND Ore. (KPTV) - A first of its kind surgery to help people with a specific type of heart failure is going through clinical trials at Providence St. Vincent’s valve center. As a part of FOX 12’s ...

During the AHA Scientific Sessions 2025, a session was presented that focused on clinical trials related to cutting edge valve and coronary care. Cardiovascular and operative mortality is lower with ...

The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide.

Lack of diversity in clinical trial populations can affect the generalizability of the results, and a new review suggests that in valvular heart disease trials, the level of representation hasn’t ...

Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ ...

SAN FRANCISCO — In two forms of severe mitral valve disease with high rates of mortality and limited treatment options, multicenter trials with novel transcatheter devices produced what experts ...

MARLBOROUGH, Mass. and WASHINGTON, Oct. 30, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the results of the primary endpoint of the ACURATE IDE clinical trial, which ...

LONDON — Opinions about the relative value of interventions to control mitral regurgitation secondary to heart failure might be altered by two large randomized trials. The RESHAPE-HF2 trial showed ...